Pharmacy World and Science

, Volume 21, Issue 6, pp 251–255 | Cite as

Abuse/misuse of non‐prescription drugs

  • G. F. Hughes
  • J.C. McElnay
  • C.M. Hughes
  • P. McKenna
Article

Abstract

Aim: To investigate the abuse of non‐prescription (over‐the‐counter; OTC) products in Northern Ireland. Method: A structured questionnaire covering various aspects of OTC drug abuse was mailed to all 509 community pharmacies in Northern Ireland. Results: 253 responses were received (response rate 49.7%) after two mailings. Pharmacists named 112 OTC products they perceived were being abused in Northern Ireland. These were classified into 8 groups, with opioids, antihistamines and laxatives the most frequently reported. The frequency of abuse of all product groups was perceived to be either increasing or static. The number of clients suspected of abuse over a three‐month period ranged from 0 to 700 (median=10, mode=6) with 55% being regular customers. Pharmacists employed several methods to limit patient access to products of abuse. The most common technique was to keep the product out of sight. Others included additional client questioning, providing advice and limiting the quantity of product sold. The majority of respondents agreed their role could be extended to include other methods of dealing with abusers, including participation in harm‐reduction programmes to wean abusers off products. Geographical region and location of pharmacy were not significant factors in the abuse of OTC products. Conclusions: Pharmacists in Northern Ireland perceive abuse and misuse of OTC products to be occurring in practice. Current methods employed for dealing with it are inadequate. Research into methods of effectively dealing with OTC abuse/misuse is required and has commenced on the basis of these findings.

Abuse Misuse Non‐prescription medicines Over‐the‐counter products Pharmacist 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    British Medical Association. The Misuse of Drugs. United Kingdom: Harwood Academic Publishers, 1997:25-7.Google Scholar
  2. 2.
    Sakol MS, Stark CR. Codeine abuse. Lancet 1989,2(8674): 1282.Google Scholar
  3. 3.
    Jensen S, Hansen AC. Abuse of codeine separated from overthe-counter drugs containing acetylsalicylic acid and codeine. Int J Leg Med 1993,105:279-81.Google Scholar
  4. 4.
    Todd GRG, Blair ALT, McElnay JC, Riddell JG. Dependence on Kaolin and Morphine Mixture, Hypokalaemia and Hypertension. Ir J Med Sci 1985;154:409-10.Google Scholar
  5. 5.
    Barragry JM, Morris DV. Fatal Dependence on Kaolin and Morphine Mixture. Postgrad Med J, 1980;56:180-1.Google Scholar
  6. 6.
    Atkinson MK. Misuse of Cyclizine. Pharm J 1985;235:773.Google Scholar
  7. 7.
    Bassett KE, Schunk JE, Insley Crouch B. Cyclizine Abuse by Teenagers in Utah. Am J Emerg Med 1996;14:472-4.Google Scholar
  8. 8.
    Rowe C, Verjee Z, Koren G. Adolescence Dimenhydrinate Abuse: Resurgence of an Old Problem. J Adolesc Health 1997;21:47-9.Google Scholar
  9. 9.
    Northern Ireland Regional Drug and Poisons Information Service. Abuse of Over-the-Counter Products. Pharmacy Update 1996;14:1-4.Google Scholar
  10. 10.
    Leighton KM. Paranoid Psychosis After Abuse of Actifed. Br Med J 1982;284:789-90.Google Scholar
  11. 11.
    Abed RT, Clarke PJ. Acute Psychotic Episode Caused by the Abuse of Phensedyl. Br J Psychiatry 1987;151:868.Google Scholar
  12. 12.
    Lambert MT. Paranoid Psychosis After Abuse of Proprietary Cold Remedies. Br J Psychiatry 1987;151:548-50.Google Scholar
  13. 13.
    Whitehouse AM, Duncan JM. Ephedrine Psychosis Rediscovered. Br J Psychiatry 1987;150:258-61.Google Scholar
  14. 14.
    Craig DF. Psychosis with Vicks Formula 44-D Abuse. Can Med Assoc J 1992;146:1199-200.Google Scholar
  15. 15.
    Vanin JR, Saylor KE. Laxative Abuse: A Hazardous Habit for Weight Control. College Health 1989;37:227-30.Google Scholar
  16. 16.
    Wills S. Drugs and Substance Misuse: Over-the-Counter Products. Pharm J 1993;251:807-10.Google Scholar
  17. 17.
    Muller-Lissner SA. Adverse Effects of Laxatives: Fact and Fiction. Pharmacology 1993;47(supp 1):138-45.Google Scholar
  18. 18.
    Baker EH, Sandle GI. Complications of Laxative Abuse. Annu Rev Med 1996;47:127-34.Google Scholar
  19. 19.
    Meyers AM, Feldman C, Sonnekus MI, Ninin DT, Margolius LP, Whalley NA. Chronic Laxative Abusers with Pseudo-idiopathic Oedema and Autonomous Pseudo-Bartter's Syndrome: A Spectrum of Metabolic Madness, or New Lights on an Old Disease? S Afr Med J 1990;78:631-36.Google Scholar
  20. 20.
    Ball K, Wilde M. OTC Medicines Misuse in West Cumbria. Pharm J 1989;242:40.Google Scholar
  21. 21.
    Paxton R, Chapple P. Misuse of Over-the-Counter Medicines: A Survey in One English County. Pharm J 1996;256:313-5.Google Scholar
  22. 22.
    Pharmaceutical Society of Northern Ireland. Ethics and Practice: A Guide for Pharmacists in Northern Ireland. 1997 edition. Belfast: Pharmaceutical Society of Northern Ireland, 1997:34-6.Google Scholar
  23. 23.
    Royal Pharmaceutical Society of Great Britain. Medicines, Ethics and Practice. A Guide for Pharmacists. Number 18. London: Royal Pharmaceutical Society of Great Britain, 1997:70-2.Google Scholar
  24. 24.
    Grieve D. Britain's Secret Army. The Nutritional Therapy Today Magazine 1997;7.Google Scholar
  25. 25.
    Temple DJ. Harm-reduction. Chemist and Druggist 1996; 245(6036):730-1.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • G. F. Hughes
  • J.C. McElnay
  • C.M. Hughes
  • P. McKenna

There are no affiliations available

Personalised recommendations